MetLife Expands Usage-Based Auto Insurance Program with New App to Help Drivers Stay Safer and Lower Their Rates
The My Journey program app automatically tracks key driving behaviors, including total miles driven, time of day, road type and conditions, hard braking and harsh acceleration, and phone-based distracted driving, in order to arrive at a score for each trip. The app does so by leveraging the sensors that are built into smartphones to continuously analyze data as the car is in motion. The app calculates and immediately displays an overall score for each trip from 1-100, with 100 being the safest possible trip. A cumulative safety score is built as time goes by.
“Today’s drivers face more distractions on the road than ever, which increases the risk of driving and puts upward pressure on car insurance rates,” noted
Through the app, drivers can get a good idea of how they drive, as well as when and by what they are being distracted, so they can alter their behavior and become safer drivers. Drivers who enroll in the program immediately get ten percent off MetLife Auto & Home’s standard rates. After drivers spend six months in the program, MetLife Auto & Home will have enough driving data calculate a discount , and careful behavior will be rewarded with rates up to 30 percent off at the following renewal. Rates are not being increased as a result of information gathered, and the My Journey mobile app is free to those who enroll in the program.
“Our technology gives MetLife Auto & Home customers feedback that helps them become better drivers and makes the roads safer for all,” said
The smartphone-enabled My Journey program is now available in
About MetLife Auto & Home:
MetLife Auto & Home is one of the nation’s leading personal lines insurance groups, insuring more than 4 million autos and homes, and is affiliated with MetLife. For more information, visit www.metlife.com.
About MetLife
About TrueMotion
Headquartered in
View source version on businesswire.com: http://www.businesswire.com/news/home/20170518005689/en/
[email protected]
Source:



FDA’s Pazdur Outlines How Oncology Center of Excellence Will Promote Collaboration in AJMC®’s Evidence-Based Oncology™
Advisor News
- Americans unprepared for increased longevity
- More investors will seek comprehensive financial planning
- Midlife planning for women: why it matters and how advisors should adapt
- Tax anxiety is real, although few have a plan to address it
- Trump targets ‘retirement gap’ with new executive order
More Advisor NewsAnnuity News
- AIG to sell remaining shares in Corebridge Financial
- Corebridge Financial, Equitable Holdings post Q1 earnings as merger looms
- AM Best Assigns Credit Ratings to Calix Re Limited
- Transamerica introduces new RILA with optional income features
- Transamerica introduces RILA with optional income features
More Annuity NewsHealth/Employee Benefits News
- Health insurance stats, Juneteenth update, bistro closes: Wednesday news roundup
- NC House lawmakers push for better breast cancer detection
- Senate approves bills to limit costs for inhalers and diabetes supplies
- Democratic candidates revive single-payer promise as California’s healthcare system faces strain
- How hospital outpatient departments increase the cost of care
More Health/Employee Benefits NewsLife Insurance News
- Equitable-Corebridge merger casts shadow over life insurance earnings
- When an MEC is an effective planning tool
- Lincoln Financial Reports 2026 First Quarter Results
- Brighthouse Financial Announces First Quarter 2026 Results
- Life insurance premium jumps 10% in 1Q
More Life Insurance News